Evidence map›Paper›PMID 25222271›Full record

ArticleNature communications2014

Archaerhodopsin variants with enhanced voltage-sensitive fluorescence in mammalian and Caenorhabditis elegans neurons.

Nicholas C Flytzanis, Claire N Bedbrook, Hui Chiu, Martin K M Engqvist, Cheng Xiao, Ken Y Chan, Paul W Sternberg, Frances H Arnold, Viviana Gradinaru

Abstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Observing and Quantifying Fluorescent Reporters.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Nicholas C Flytzanis1] Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA [2].
Claire N Bedbrook1] Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA [2].
Hui ChiuDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Martin K M EngqvistDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Cheng XiaoDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Ken Y ChanDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Paul W SternbergDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Frances H Arnold1] Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA [2] Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Viviana GradinaruDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA.

Funding

PREDOCTORAL TRAINING IN BIOLOGY AND CHEMISTRYT32GM007616 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI STERNBERG, PAUL WARREN · 1985 to 2019
$22.9M
Neuromodulation and Neurodegeneration: the Missing Link and Mechanisms of ActionDP2NS087949 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI GRADINARU, VIVIANA · 2013 to 2019
$4.1M
Intact Circuit Assessment of Aging Dopamine Neurons vis Optogenetics and CLARITYR01AG047664 · NIA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI GRADINARU, VIVIANA · 2014 to 2018
$2.0M
The Gut Microbiome in Neurodegenerative DiseaseR01NS085910 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MAZMANIAN, SARKIS K · 2013 to 2016
$1.3M
Engineering Microbial Opsins for Neuroscience via Structure-Guided RecombinationR21MH103824 · NIMH · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ARNOLD, FRANCES H, GRADINARU, VIVIANA · 2014 to 2015
$458k
NIA NIH HHS NIH 1R01AG047664-01NIA NIH HHS R01 AG047664NIGMS NIH HHS NIH/NRSA 5T32GM07616NIGMS NIH HHS T32 GM007616NIMH NIH HHS NIH 1R21MH103824-01NIMH NIH HHS R21 MH103824NINDS NIH HHS DP2 NS087949NINDS NIH HHS NIH 1R01NS085910-01NINDS NIH HHS R01 NS085910PHS HHS IDP20D017782-01
6 · The paper itself

Abstract

Probing the neural circuit dynamics underlying behaviour would benefit greatly from improved genetically encoded voltage indicators. The proton pump Archaerhodopsin-3 (Arch), an optogenetic tool commonly used for neuronal inhibition, has been shown to emit voltage-sensitive fluorescence. Here we report two Arch variants with enhanced radiance (Archers) that in response to 655 nm light have 3-5 times increased fluorescence and 55-99 times reduced photocurrents compared with Arch WT. The most fluorescent variant, Archer1, has 25-40% fluorescence change in response to action potentials while using 9 times lower light intensity compared with other Arch-based voltage sensors. Archer1 is capable of wavelength-specific functionality as a voltage sensor under red light and as an inhibitory actuator under green light. As a proof-of-concept for the application of Arch-based sensors in vivo, we show fluorescence voltage sensing in behaving Caenorhabditis elegans. Archer1's characteristics contribute to the goal of all-optical detection and modulation of activity in neuronal networks in vivo.

Indexed as

Action PotentialsAnimalsArchaeal ProteinsCaenorhabditis elegansGene ExpressionHelminth ProteinsHippocampusLightNerve Tissue ProteinsNeuronsOptogeneticsPatch-Clamp TechniquesPrimary Cell CultureProtein IsoformsProton PumpsRatsArchaeal Proteinsarchaerhodopsin protein, ArchaeaHelminth ProteinsNerve Tissue ProteinsProtein IsoformsProton PumpsRecombinant Proteins

Identifiers

PMID25222271
PMCPMC4166526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.